Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Zevra Therapeutics granted options to purchase 33,000 shares of common stock to four new employees. The awards were issued under Nasdaq Listing Rule 5635(c)(4) as inducements material to the employees' entry into employment.
Key figures
- New employees
- 4
- Shares granted
- 33000
- Vesting period years
- 4
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.